TABLE 3.
Experimentally determined parameters from SAXS analysis of ligand-free and ligand-bound GASP proteins
| Sample | Concentration | I(0) |
Rg |
Dmax | Volume | Molecular mass | DAMMIF NSDa | |
|---|---|---|---|---|---|---|---|---|
| Gunier | Real space | |||||||
| mg/ml | cm−1 | Å | Å | Å3 | Da | Å | ||
| GASP-1 | 2.6 | 682 | 53.1 | 53.85 | 177 | 347,796 | 86,000 | |
| 1.6 | 393 | 51.9 | 52.06 | 172 | 341,665 | 75,600 | 0.945 ± 0.06 | |
| 1 | 240 | 51 | 50.97 | 168 | 341,668 | 67,500 | ||
| GASP-1·myostatin | 1.4 | 396 | 49.1 | 48.12 | 163 | 432,793 | 112,000 | |
| 1.2 | 303 | 47.5 | 46.52 | 160 | 433,075 | 96,700 | 1.034 ± 0.057 | |
| 1 | 252 | 48.8 | 46.33 | 161 | 422,324 | 102,000 | ||
| GASP-2 | 3 | 556 | 46.3 | 46.19 | 151 | 321,500 | 77,600 | |
| 2 | 369 | 45.6 | 43.51 | 147 | 326,803 | 71,300 | 0.828 ± 0.047 | |
| 1 | 191 | 44.8 | 41.19 | 141 | 316,598 | 61,000 | ||
| GASP-2·myostatin | 3 | 1130 | 62.6 | 64.83 | 205 | 595,832 | 211,000 | |
| 2 | 661 | 60.5 | 63.32 | 210 | 589,810 | 189,000 | 1.488 ± 0.478 | |
| 1 | 336 | 58.1 | 59.97 | 200 | 528,526 | 162,000 | ||
| MBP GASP-1 WFIK·myostatin | 3 | 357 | 56.7 | 56.5 | 173 | 376,242 | 179,000 | |
| 2 | 249 | 55.6 | 55.1 | 167 | 337,781 | 167,000 | ||
| 1 | 127 | 52.7 | 54.5 | 168 | 349,291 | 174,000 | ||
a NSD, normalized spatial discrepancy.